{
    "clinical_study": {
        "@rank": "117680", 
        "arm_group": {
            "arm_group_label": "FOLFOX6+Metformin/FOFIRI+Metformin", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "To determine the safety and efficacy of second-line treatment with Metformin and\n      Chemotherapy (FOLFOX6 or FOFIRI) in the second line treatment of advanced colorectal cancer"
        }, 
        "brief_title": "A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal Cancer", 
        "condition": "Previously Treated Advanced Colorectal Cancer", 
        "condition_browse": {
            "mesh_term": "Colorectal Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age over 18\n\n          -  histologically confirmted advanced colorectal cancer\n\n          -  ECOG PS 0-2\n\n          -  expected life span more than 3months\n\n          -  normal bone marrow, liver, renal function\n\n        Exclusion Criteria:\n\n          -  5-FU, oxaliplatin, irinotecan or Metformin Allergic history\n\n          -  Lactic acidosis, metabolic acidosis\n\n          -  active infection or severe neuropathy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "48", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01926769", 
            "org_study_id": "2012-GIRBA-2675"
        }, 
        "intervention": {
            "arm_group_label": "FOLFOX6+Metformin/FOFIRI+Metformin", 
            "intervention_name": "Metformin", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Metformin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Colorectal cancer", 
            "Metformin", 
            "FOLFOX6", 
            "FOFIRI", 
            "5FU", 
            "irinotecan", 
            "oxaliplatin"
        ], 
        "lastchanged_date": "August 19, 2013", 
        "location": {
            "contact": {
                "last_name": "Hee Kyung Ahn", 
                "phone": "+82-32-460-3220"
            }, 
            "facility": {
                "address": {
                    "city": "Incheon", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Gachon University Gil Medical Center"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Disease Control Rate", 
            "safety_issue": "No", 
            "time_frame": "one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01926769"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Gachon University Gil Medical Center", 
            "investigator_full_name": "Hee Kyung Ahn", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Response Rate", 
                "safety_issue": "No", 
                "time_frame": "one year"
            }, 
            {
                "measure": "Overall Survival", 
                "safety_issue": "No", 
                "time_frame": "one year"
            }, 
            {
                "measure": "Number of participants with adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "one year"
            }, 
            {
                "measure": "Progression Free Survival", 
                "safety_issue": "No", 
                "time_frame": "one year"
            }
        ], 
        "source": "Gachon University Gil Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Gachon University Gil Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}